CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...
Phase 1
Cleveland, Ohio, United States and 8 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Cleveland, Ohio, United States and 124 other locations
with chemotherapy in participants with previously untreated advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma...
Phase 2, Phase 3
Cleveland, Ohio, United States and 157 other locations
first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Cleveland, Ohio, United States and 207 other locations
This study is open to adults with advanced pancreatic cancer. The study tests a type of immunotherapy. It is a protein treatment combined with a viru...
Phase 1
Cleveland, Ohio, United States and 20 other locations
This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitiza...
Phase 2
Cleveland, Ohio, United States and 89 other locations
This trial studies tucatinib to find out if it is safe when given with trastuzumab and other anti-cancer drugs (pembrolizumab, FOLFOX, and CAPOX). It...
Phase 2
Cleveland, Ohio, United States and 26 other locations
A multicenter, single-arm, first-in-human study to investigate the safety, pharmacokinetics, and preliminary antitumor activity of PLX-61639 in parti...
Phase 1
Cleveland, Ohio, United States and 9 other locations
The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safet...
Phase 1
Cleveland, Ohio, United States and 10 other locations
Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...
Phase 3
Cleveland, Ohio, United States and 148 other locations
Clinical trials
Research sites
Resources
Legal